Multiple Sclerosis Therapy Monitoring Based on Gene Expression

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|29|3761-3779

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.29, 2006-10, pp. : 3761-3779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon-Beta Therapy Monitoring in Multiple Sclerosis Patients

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 1, 2009-03 ,pp. : 14-28

Bentham Science Publishers

Access to resources Recommend Favorite

Monitoring Therapy with Gene Expression Profiling Reveals Physiological Differences in Drug Action

By  

Current Pharmaceutical Design, Vol. 10, Iss. 16, 2004-06 ,pp. : 1959-1968

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Antioxidative Therapy of Multiple Sclerosis

By  

Current Medicinal Chemistry, Vol. 20, Iss. 37, 2013-11 ,pp. : 4720-4730

Bentham Science Publishers

Access to resources Recommend Favorite

Teriflunomide for oral therapy in multiple sclerosis

By Papadopoulou Athina   Kappos Ludwig   Sprenger Till  

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 617-628

Informa Healthcare

Access to resources Recommend Favorite

Basic and escalation therapy of multiple sclerosis

By  

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 414-421

Govi-Verlag

Access to resources Recommend Favorite